S&P 500

AMGN

Amgen Inc.

latest move

-12.75%

2026-09-14

4 sessions · 2026-09-08 → 2026-09-14 · avg 12.87% · largest 15.03%

Amgen Inc. is an independent biotechnology company that develops human therapeutics in oncology, hematology, cardiovascular disease, inflammatory conditions, and rare diseases.

Price history

stitched from the price window carried by each report

Every session it moved

newest first

2026-09-14Neutral

-12.75%weekly change

Shares dropped after competitor Novartis reported a Phase 3 trial failure for a drug targeting the same cardiovascular biomarker.

read the report →

2026-09-11Bullish

-15.03%weekly change

Novartis's Phase 3 trial failure for a similar cardiovascular drug triggered pipeline concerns and analyst downgrades for Amgen.

read the report →

2026-09-10Bearish

-13.63%weekly change

Amgen fell due to a rival's drug trial failure impacting its pipeline, analyst downgrades, and regulatory suspensions of Tavneos.

read the report →

2026-09-08Neutral

-10.08%24 hours change

Shares dropped after competitor Novartis's Phase 3 Lp(a) trial failed, raising pipeline risks, alongside an analyst downgrade.

read the report →